RecruitingNot ApplicableNCT06269666
P200TxE Diseased Eye Image Collection
Sponsor
Optos, PLC
Enrollment
100 participants
Start Date
Jan 31, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The primary objective is to collect images on the P200TxE device in diseased eyes.
Eligibility
Min Age: 22 Years
Inclusion Criteria6
- Male or female subjects 22 years of age or older who have full legal capacity to subject on the date the informed consent is signed;
- Subjects who can follow the instructions by the clinical staff at the clinical site;
- Subjects who agree to participate;
- Subjects who have been diagnosed with retinal pathology and/or glaucoma that affects the posterior pole region including the macula and/or optic nerve.
- For glaucoma subjects:
- a. Glaucoma subjects who have a history of visual field loss and RNFL or optic nerve changes.
Exclusion Criteria2
- Subjects unable to tolerate ophthalmic imaging;
- Subjects with ocular media not sufficiently clear to obtain acceptable images.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEP200TxE
SLO and OCT imaging
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06269666
Related Trials
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
NCT011451961 location
Cell Collection to Study Eye Diseases
NCT014328471 location
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
NCT063800751 location
National Eye Institute Biorepository for Retinal Diseases
NCT014966251 location
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
NCT068415751 location